KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Cash from Investing Activities (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Cash from Investing Activities for 16 consecutive years, with -$741.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 2616.24% to -$741.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$545.8 million through Dec 2025, down 107.75% year-over-year, with the annual reading at -$545.8 million for FY2025, 107.75% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$741.8 million at Halozyme Therapeutics, down from $201.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $201.6 million in Q3 2025, with the low at -$741.8 million in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$89.9 million, with a median of -$44.9 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities plummeted 8178.77% in 2023, then soared 455.57% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$299.5 million in 2021, then soared by 99.42% to -$1.7 million in 2022, then tumbled by 374.86% to -$8.3 million in 2023, then skyrocketed by 455.57% to $29.5 million in 2024, then crashed by 2616.24% to -$741.8 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$741.8 million, $201.6 million, and $84.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.